Financhill
Back

Neurogene 10K Form

Sell
20

NGNE
Neurogene

Last Price:
25.58
Seasonality Move:
25.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NGNE News And Ratings

See the #1 stock for the next 7 days that we like better than NGNE

NGNE Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-15.73M
Price / Cash Flow: 0
Annual Sales: $10.56
Price / Book: 2.75

Profitability

EPS (TTM): -3.09420
Net Income (TTM): $-53.25M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Neurogene Earnings Forecast

Key Neurogene Financial Ratios

  • The Interest Expense is -0.03% of Operating Income.
  • Per Share Earnings over the last 3 years have been positive in 0 years.

Neurogene Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NGNE
Website: neurogene.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NGNE Technical Analysis vs Fundamental Analysis

Sell
20
Neurogene (NGNE) is a Sell

Is Neurogene a Buy or a Sell?

  • Neurogene stock is rated a Sell
    The current Neurogene [NGNE] share price is $25.43. The Score for NGNE is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.